Tumor necrosis factor-alpha/antagonists inhibitors [Majr] OR tumor necrosis factor-alpha/therapeutic use [Majr] AND cardiovascular diseases [Majr] AND arthritis, rheumatoid [Majr]. This evidence concerns the gene TNF and cardiovascular disorder.